Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divergent protein kinase domain 2A (DIPK2A, also C3orf58, DIA1, HASF, GoPro49, among other aliases) encodes a protein believed to function as a kinase localized in the Golgi membrane and the extracellular space. It participates in signal transduction pathways with roles in cardiac cell proliferation via paracrine signaling and activation of the PI3-kinase, AKT, and CDK7 signaling pathway. It is associated with neurodevelopmental disorders such as autism and intellectual disabilities. Its protein structure relates to the divergent protein kinase domain family, indicating possible kinase activity that may be regulated by calcium, but its exact substrates and druggability remain poorly defined
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divergent protein kinase domain 2A (DIPK2A).